Over the past two decades, plastic and reconstructive surgery has come to rely on tracking outcomes, noting complications, and assessing patient-reported outcomes to assess the effectiveness of procedures performed. The International Society of Aesthetic Plastic Surgery reported a rise in aesthetic procedures performed globally in 2022, with over 30 million procedures performed worldwide. As the volume of procedures increases, professional organizations are promoting transparency, audit, and improvement. Besides skill, a clinical practice must show safety, effectiveness, and outcomes that are important to patients, all measured against specified criteria.
In Canada, this change mirrored the growth of administrative databases and peer-reviewed research. The Canadian Institute for Health Information has recorded a continuous increase in elective surgical volumes since the mid 2000s, making standardized reporting more of a necessity. Canadian studies on complications, access disparities, and long-term psychosocial outcomes have been published in journals such as Plastic and Reconstructive Surgery, Journal of Plastic, Reconstructive and Aesthetic Surgery, Annals of Surgical Oncology, and Journal of Clinical Oncology. These publications have contributed to comparing reconstructive methods and identifying institutional risk factors.
In this broader scope, Edelstein Cosmetic Plastic Surgery is the practice of Dr. Jerome Edelstein in the city of Toronto, Canada. It is a private practice, but it exists within a professional culture shaped by the influence of research and evidence-based practice. Among the surgeons who work in the facility, Dr. Zhong, Dr. Hofer, and Dr. Fialkov have published studies on complication rates, decision regret, barriers to access, and differences in outcomes of surgeries.
Alongside studies led by Dr. Zhong, Dr. Fialkov has authored and co-authored scholarly chapters on craniofacial reconstruction and tissue engineering, including contributions to “Bone Engineering” and “Facial Trauma Surgery: From Primary Repair to Reconstruction.” These works reflect the wider movement in plastic surgery toward systematic evaluation rather than anecdotal assessment.
A significant area of research has involved comparing reconstructive techniques and their complication profiles. A 2014 propensity score analysis in Plastic and Reconstructive Surgery compared rates of major complications between deep inferior epigastric perforator flaps and muscle-sparing TRAM flaps. By adjusting for patient characteristics, the study evaluated differences in post-operative morbidity. Chemotherapy delivery has also been shown to be affected by complication rates in immediate breast reconstruction, a subject examined in further analyses in 2011 and 2018. Complementing this body of work, Dr. Fialkov’s earlier publications on bone substitutes in craniofacial surgery and in vivo tissue engineering models addressed reconstructive strategy at a biomaterial and structural level, reinforcing the integration of surgical technique with foundational research.
Determining patient risk and guiding operative decision-making have also been addressed in publications affiliated with the clinic’s surgeons. A decision-making algorithm for selecting the recipient vein in bipedicle flap reconstruction was described in 2014 in the Journal of Plastic, Reconstructive, and Aesthetic Surgery. Studies have also examined intravenous fluid infusion rates in microsurgical reconstruction in relation to flap outcomes. These investigations illustrate that perioperative variables can be systematically studied and improved. They also show that changes in practice were evaluated through prospective cohorts and controlled trials rather than accepted solely on tradition.
Patient-reported outcome measures have become another cornerstone of quality improvement. Since 2013, publications have addressed the development and validation of instruments used to measure satisfaction and health-related quality of life. Articles in Clinics in Plastic Surgery and Plastic and Reconstructive Surgery discussed the principles required for reliable assessment. In 2015, Korus, Zhong, and Wu evaluated the role of generic outcome measures in reconstructive breast surgery. These contributions emphasize quantifying psychosocial recovery alongside surgical success.
Access and system-level variation have also been addressed through population-based studies. In 2014, an article published in the Journal of Clinical Oncology examined what contributes to the difficulty of immediate reconstruction accessibility in the Canadian universal healthcare system. Shortly thereafter, an article published in the World Journal of Surgery called attention to the differences in reconstruction and surgeon availability. The aforementioned articles put reconstructive outcomes in the larger context of healthcare system construction. Today, the perioperative experience is viewed as part of an ongoing quality improvement cycle, much like surgical skill sets. In 2013 and 2014, randomized trials were performed to examine transversus abdominis plane blocks. The results were published in Plastic and Reconstructive Surgery and Trials. These trials were intended to reduce the use of morphine and hasten initial recovery. Other studies have demonstrated that the implementation of restrictive transfusion practices and standardized antibiotic prophylaxis does not increase complication risk. This supports the trend of transitioning perioperative care to standardized practices based on outcomes.
Long-term complication tracking has also informed practice evolution. Research on capsular contracture, need for reoperations, and results of implants has been published in the Annals of Surgical Oncology and other similar scientific journals. A population-based study of reoperations after post-mastectomy reconstruction has further elucidated the longevity of the results obtained. Monitoring revision rates contributes to understanding sustained patient satisfaction. Regulatory reporting frameworks in Ontario reinforce structured follow-up and documentation.
Another aspect of how this research integrates into practice is the way that the recommendations are kept aligned with the latest research. For example, the International Society of Aesthetic Plastic Surgery and the Canadian Society of Plastic Surgeons provide recommendations based on the latest evidence. In a controlled environment, this is how clinics operate rather than attempting to use unproven techniques. Edelstein Cosmetic Plastic Surgery is a clinic that does this.
Since its establishment in 2006, Dr. Jerome Edelstein’s practice has operated within a research-informed framework shaped by contributions from Dr. Zhong, Dr. Hofer, Dr. Fialkov, and collaborators. Published analyses on complication reduction, access disparities, perioperative optimization, and reconstructive biomaterials demonstrate how clinical observation and foundational research inform each other. Within contemporary plastic surgery, quality improvement is a continuous process. Edelstein Cosmetic Plastic Surgery represents a private practice situated within a broader network of evidence-based reconstructive and aesthetic care.
Disclaimer: The information provided is for general educational and informational purposes only. It is not intended as medical advice and should not be considered a substitute for professional consultation, diagnosis, or treatment. Always seek the guidance of a qualified healthcare professional regarding any medical condition or procedure. Individual results may vary, and past outcomes do not guarantee future results.
